BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32888056)

  • 1. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.
    Li Y; Yang X; Wang N; Wang H; Yin B; Yang X; Jiang W
    Mol Genet Genomics; 2020 Nov; 295(6):1537-1546. PubMed ID: 32888056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
    Dutta R; Buragohain L; Borah P
    Virus Res; 2020 Oct; 288():198113. PubMed ID: 32771430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of codon usage pattern in SARS-CoV-2.
    Hou W
    Virol J; 2020 Sep; 17(1):138. PubMed ID: 32928234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
    Nambou K; Anakpa M
    Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular features similarities between SARS-CoV-2, SARS, MERS and key human genes could favour the viral infections and trigger collateral effects.
    Maldonado LL; Bertelli AM; Kamenetzky L
    Sci Rep; 2021 Feb; 11(1):4108. PubMed ID: 33602998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betacoronaviruses genome analysis reveals evolution toward specific codons usage: Implications for SARS-CoV-2 mitigation strategies.
    Lopes EN; Fonseca V; Frias D; Tosta S; Salgado Á; Assunção Vialle R; Paulo Eduardo TS; Barreto FK; Ariston de Azevedo V; Guarino M; Angeletti S; Ciccozzi M; Junior Alcantara LC; Giovanetti M
    J Med Virol; 2021 Sep; 93(9):5630-5634. PubMed ID: 33934387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Societal considerations in host genome testing for COVID-19.
    Milne R
    Genet Med; 2020 Sep; 22(9):1464-1466. PubMed ID: 32514089
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
    Das JK; Roy S
    Genomics; 2021 Jul; 113(4):2177-2188. PubMed ID: 34019999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
    COVID-19 Host Genetics Initiative
    Eur J Hum Genet; 2020 Jun; 28(6):715-718. PubMed ID: 32404885
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 outcomes and the human genome.
    Murray MF; Kenny EE; Ritchie MD; Rader DJ; Bale AE; Giovanni MA; Abul-Husn NS
    Genet Med; 2020 Jul; 22(7):1175-1177. PubMed ID: 32393819
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.
    Mogro EG; Bottero D; Lozano MJ
    Virology; 2022 Mar; 568():56-71. PubMed ID: 35134624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of genome composition and codon usage patterns of emerging coronaviruses.
    Tort FL; Castells M; Cristina J
    Virus Res; 2020 Jul; 283():197976. PubMed ID: 32294518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
    Am J Med Genet A; 2020 Sep; 182(9):1998-1999. PubMed ID: 32881367
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
    Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
    Elife; 2020 May; 9():. PubMed ID: 32452762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host.
    Hussain S; Rasool ST; Pottathil S
    J Mol Evol; 2021 Jul; 89(6):341-356. PubMed ID: 33993372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sampling the host response to SARS-CoV-2 in hospitals under siege.
    Charney AW; Simons NW; Mouskas K; Lepow L; Cheng E; Le Berichel J; Chang C; Marvin R; Del Valle DM; Calorossi S; Lansky A; Walker L; Patel M; Xie H; Yi N; Yu A; Kang G; Mendoza A; Liharska LE; Moya E; Hartnett M; Hatem S; Wilkins L; Eaton M; Jamal H; Tuballes K; Chen ST; Tabachnikova A; Chung J; Harris J; Batchelor C; Lacunza J; Yishak M; Argueta K; Karekar N; Lee B; Kelly G; Geanon D; Handler D; Leech J; Stefanos H; Dawson T; Scott I; Francoeur N; Johnson JS; Vaid A; Glicksberg BS; Nadkarni GN; Schadt EE; Gelb BD; Rahman A; Sebra R; Martin G; ; Marron T; Beckmann N; Kim-Schulze S; Gnjatic S; Merad M
    Nat Med; 2020 Aug; 26(8):1157-1158. PubMed ID: 32719485
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 continuously optimizes its codon usage to adapt to human lung environment.
    Wang Y; Li Z; Wang X; Jiang W; Jiang W
    J Appl Genet; 2023 Dec; 64(4):831-837. PubMed ID: 37740828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2.
    Li G; Zhang L; Xue P
    Infect Genet Evol; 2022 Jan; 97():105175. PubMed ID: 34871776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.